Landscape of tumor mutational burden-high (TMB-high) and its correlation with immune checkpoint inhibitor biomarkers in gynecologic tumors

被引：0
|
作者：
Huang, Richard [1 ]
Lin, Douglas [1 ]
Danziger, Natalie [1 ]
Williams, Erik [2 ]
Elvin, Julia [1 ]
机构：
[1] Fdn Med Inc, Raleigh, NC USA
[2] UCSF & Fdn Med, San Francisco, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
371
引用
收藏
页码：S196 / S196
页数：1
相关论文
共 50 条
  • [1] Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
    Palmeri, M.
    Mehnert, J.
    Silk, A. W.
    Jabbour, S. K.
    Ganesan, S.
    Popli, P.
    Riedlinger, G.
    Stephenson, R.
    de Meritens, A. B.
    Leiser, A.
    Mayer, T.
    Chan, N.
    Spencer, K.
    Girda, E.
    Malhotra, J.
    Chan, T.
    Subbiah, V
    Groisberg, R.
    [J]. ESMO OPEN, 2022, 7 (01)
  • [2] Clinical Validation of Tumor Mutational Burden (TMB) in Solid Tumors by NGS: Impact of Revised TMB-High Threshold
    Parimi , Vamsi
    Xian, Rena
    Lin, Ming-Tseh
    Eshleman, James
    Gocke, Christopher
    Pallavajjala, Aparna
    [J]. MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1071 - 1072
  • [3] Clinical Validation of Tumor Mutational Burden (TMB) in Solid Tumors by NGS: Impact of Revised TMB-High Threshold
    Parimi , Vamsi
    Xian, Rena
    Lin, Ming-Tseh
    Eshleman, James
    Gocke, Christopher
    Pallavajjala, Aparna
    [J]. LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1071 - 1072
  • [4] Association between tumor mutational burden (TMB) and mutational profile and its effect on overall survival: A post hoc analysis of patients with TMB-high and TMB-low metastatic cancer treated with immune checkpoint inhibitors (ICI)
    Xavier, Camila Braganca
    Guardia, Gabriela
    Lopes, Carlos Diego Holanda
    Awni, Beatriz Mendes
    Campos, Eduardo Felicio
    Alves, Joao Pedro
    Camargo, Anamaria Aranha
    Galante, Pedro Alexandre Favoretto
    Jardim, Denis L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Tumor mutational burden (TMB) as a predictive biomarker of immune checkpoint blockade (ICB) in metastatic solid tumors
    Kao, Chester
    Powers, Eric
    Datto, Michael B.
    Green, Michelle
    Harrison, Michael Roger
    Armstrong, Andrew J.
    George, Daniel J.
    Clarke, Jeffrey Melson
    Strickler, John H.
    Zhang, Tian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [6] FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid for Tumors
    Marcus, Leigh
    Fashoyin-Aje, Lola A.
    Donoghue, Martha
    Yuan, Mengdie
    Rodriguez, Lisa
    Gallagher, Pamela S.
    Philip, Reena
    Ghosh, Soma
    Theoret, Marc R.
    Beaver, Julia A.
    Pazdur, Richard
    Lemery, Steven J.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4685 - 4689
  • [7] Challenges and Future Directions in the Management of Tumor Mutational Burden-High (TMB-H) Advanced Solid Malignancies
    Ahmed, Jibran
    Das, Biswajit
    Shin, Sarah
    Chen, Alice
    [J]. CANCERS, 2023, 15 (24)
  • [8] Microsatellite-stable tumors with high tumor mutational burden in association with tumor response to immune checkpoint inhibitor therapy across solid tumors and correlation with specific oncogenic alterations
    Nizamuddin, Imran
    Doukas, Peter
    de Viveiros, Pedro Antonio Hermida
    Mi, Xinlei
    Katam, Neelima
    Chae, Young Kwang
    Behdad, Amir
    Wehbe, Firas Hazem
    Mahalingam, Devalingam
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer
    Sammons, Sarah
    Elliott, Andrew
    Force, Jeremy
    Chumsri, Saranya
    Anders, Carey
    Tan, Antoinette R.
    Magee, Daniel
    Zeng, Jia
    Korn, W. Michael
    Kahsraw, Mustafa
    Torres, Evanthia T. Roussos
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [10] Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer
    Sammons, Sarah
    Elliott, Andrew
    Barroso-Sousa, Romualdo
    Chumsri, Saranya
    Tan, Antoinette R.
    Sledge, George W.
    Tolaney, Sara M.
    Torres, Evanthia T. Roussos
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
12345